1. Home
  2. CADL vs MTC Comparison

CADL vs MTC Comparison

Compare CADL & MTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$8.34

Market Cap

641.2M

Sector

Health Care

ML Signal

N/A

MTC

MMTec Inc.

N/A

Current Price

$4.95

Market Cap

543.7M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
MTC
Founded
1999
2015
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
641.2M
543.7M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
CADL
MTC
Price
$8.34
$4.95
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
★ $22.11
N/A
AVG Volume (30 Days)
★ 905.6K
8.1K
Earning Date
11-12-2026
12-13-2024
Dividend Yield
N/A
N/A
EPS Growth
★ 58.62
N/A
EPS
N/A
★ N/A
Revenue
★ $125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$0.25
52 Week High
$14.00
$9.10

Technical Indicators

Market Signals
Indicator
CADL
MTC
Relative Strength Index (RSI) 36.89 43.85
Support Level $7.70 $4.52
Resistance Level $9.42 $4.90
Average True Range (ATR) 0.54 0.65
MACD 0.06 -0.12
Stochastic Oscillator 27.27 0.94

Price Performance

Historical Comparison
CADL
MTC

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About MTC MMTec Inc.

MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. The company offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future and HC Securities, and MM Global. The Gujia segment provides market data services and consulting services to customers in China; and MM Global segment operates as an introducing broker that clears all transactions through a clearing broker dealer and earns commission income.

Share on Social Networks: